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Abstract
Aim—To evaluate perceived risk, control, worry, and severity about diabetes, coronary heart
disease (CHD) and stroke among individuals at increased familial risk of diabetes.
Methods—Data analyses were based on the Family Healthware™ Impact Trial. Baseline health
beliefs were compared across three groups: (1) no family history of diabetes, CHD or stroke (n =
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836), (2) family history of diabetes alone (n = 267), and (3) family history of diabetes and CHD
and/or stroke (n = 978).
Results—After adjusting for age, gender, race, education and BMI, scores for perceived risk for
diabetes (p < 0.0001), CHD (p < 0.0001) and stroke (p < 0.0001) were lowest in Group 1 and
highest in Group 3. Similar results were observed about worry for diabetes (p < 0.0001), CHD (p
< 0.0001) and stroke (p < 0.0001). Perceptions of control or severity for diabetes, CHD or stroke
did not vary across the three groups.
Conclusions—Among individuals at increased familial risk for diabetes, having family
members affected with CHD and/or stroke significantly influenced perceived risk and worry.
Tailored lifestyle interventions for this group that assess health beliefs and emphasize approaches
for preventing diabetes, as well as its vascular complications, may be an effective strategy for
reducing the global burden of these serious but related chronic disorders.
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1. Introduction
During the first decade of the 21st century, the increase in the global burden of diabetes
exceeded prior predictions [1]. This was primarily the result of a rise in obesity, and a
concomitant increase in the incidence of type 2 diabetes. The most recent estimates indicate
that there are now 285 million individuals in the world with diabetes [2]. This number is
expected to climb to 439 million adults diagnosed with diabetes by 2030. In North America
alone, it is anticipated that the prevalence of diabetes will be 12%, representing a 42%
increase from the current rate.
More than three-quarter of individuals with diabetes will die from vascular complications
[3]. Myocardial infarction, stroke and peripheral artery disease are common causes of death.
In a meta-analysis of individual records from 102 prospective studies, the hazard ratios, after
adjusting for age and sex, were 2.06 (95% CI: 1.82–2.34) for coronary heart disease (CHD)
and 2.56 (95% CI: 2.15–3.05) for stroke for diabetic compared to non-diabetic individuals
[4]. As the global burden of diabetes increases, one can predict that there will be a
corresponding rise in the prevalence of CHD and stroke among affected individuals.
Based on evidence from the Diabetes Prevention Program (DPP) in the US [5] and the
Diabetes Prevention Study (DPS) in Finland [6] that diabetes and its vascular complications
can be prevented through lifestyle modifications [3,7–9], the identification of persons at
increased risk, and targeting these individuals for interventions is paramount to reducing the
global burden of these diseases. High risk individuals include those with impaired fasting
glucose or impaired glucose tolerance, as well as persons with a family history of the
disease. Family history of diabetes, which reflects the effect of shared genes and
environmental risk factors, has been consistently shown to be a significant independent risk
factor for developing the disease [10–15]. Compared to individuals with a negative family
history, those with affected relatives have a two-to six-fold increased risk of developing
diabetes. In the adult US population, approximately 30% of non-Hispanic whites have a
moderate-to-high familial diabetes risk [10]. These proportions are higher for non-Hispanic
blacks (37%) and Mexican Americans (36%).
In addition to its effect on diabetes risk, having a family history of diabetes independently
increases one's likelihood of developing its vascular complications, particularly CHD and
stroke. Scheuner et al. showed that a family history of diabetes was significantly associated
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with a positive score for coronary artery calcification [16], which is highly predictive of
major cardiovascular events. Similar findings were reported from a study of healthy young
Caucasian adults [17], as well as an investigation based on a Mexican American cohort [18].
Although the relationship between family history and stroke is less clear, a recent Korean
study reported that a positive family history of diabetes doubled the risk of stroke among
diabetic adults [19].
Given that obesity, a high-fat diet and physical inactivity increase risk of developing
diabetes [5,6], CHD [3,7] and stroke [8,9], interventions that emphasize the importance of
these three modifiable risk factors for preventing diabetes and its vascular complications
may be more effective long-term than those that focus on diabetes alone. However, it is
unclear whether healthy individuals with a family history of diabetes are aware that they at
increased risk of developing these co-morbid conditions, or attempt lifestyle modifications
to prevent their development. The few studies that have addressed these issues reported that
among individuals at increased familial diabetes risk, only about half worried [20– 24] or
perceived that they were at increased risk for developing diabetes [22–28]. A similar
proportion thought that diabetes could be prevented [21,25,26] or attempted to make
lifestyle changes to reduce their risk [26,29]. Thus, individuals at increased familial risk for
diabetes appear to have misconceptions regarding their degree of susceptibility and the risk
factors that contribute to the development of diabetes.
Health beliefs, attitudes and knowledge are major constructs of health behavior theories. In
particular, perceptions of disease risk, control, and severity are included in social cognitive
models such as the Health Belief Model [30] and the Theory of Planned Behavior [31]
because they underlie health behaviors, mediate the effects of other risk factors, are
amenable to change, and are targets for disease interventions [32]. Therefore, the
development of successful interventions for individuals at increased familial risk for
diabetes is contingent upon understanding their health beliefs regarding diabetes, CHD and
stroke. Moreover, it is important to determine whether these beliefs are influenced by the
presence of family members who are also affected CHD and/or stroke. Evidence supporting
this premise would further justify the need for multiple risk factor interventions that focus
on diabetes, as well as its vascular complications, as an approach for reducing the global
burden of these related disorders.
To our knowledge, no study has examined health beliefs regarding these three conditions
among individuals stratified by their familial risk for diabetes. We have a unique
opportunity to address this issue using data collected for the Family Healthware™ Impact
Trial (FHITr), which is the focus of this report.
2. Materials and methods
2.1. Study design
The FHITr was designed to determine whether providing tailored prevention messages,
based primarily on an individual's family health history for six chronic diseases (CHD,
stroke, diabetes, and breast, colon and ovarian cancer) influenced health behaviors and
communication about disease risk. Details regarding the study have been previously
published [33–37]. To summarize, 41 primary care practices associated with three academic
centers (NorthShore University HealthSystem in Chicago, the University of Michigan and
Case Western Reserve University in Ohio) were randomized to an intervention (23
practices; n = 2650) or control arm (18 practices; n = 1598). All participants recruited from
these practices were age 35–65 years and had no personal history of CHD, stroke, diabetes,
breast, colon or ovarian cancer. Protocols were approved by institutional review boards at
CDC and all three academic centers.
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Individuals first completed a baseline questionnaire online; these data are the focus of this
report. Included was an assessment of demographics, self-reported health status, height and
weight (for BMI calculations) and health behaviors (e.g., smoking, physical activity, fruit
and vegetable intake, alcohol use, aspirin use, and screening tests) and communications with
family members or health providers about prevention approaches for the six conditions
under study. Individuals in the intervention arm then used the interactive web-based Family
Healthware™ tool to provide information about their family health history, including first-
and second-degree relatives. This was followed by a message that included a personalized
risk assessment and recommendations for screening and lifestyle changes based on their
current health behaviors and family history. For example, individuals in the intervention
group who were moderate or high familial risk for diabetes, CHD and/or stroke, and had not
had their blood sugar tested in the past two years, received the following personalized
prevention message: “You may benefit from blood sugar testing because of your family
history. Talk to your healthcare professional about your blood sugar and how it affects your
risk of diabetes, CHD and/or stroke” [37]. This was followed by a paragraph explaining the
role of elevated blood sugar in terms of risk for diabetes, CHD and stroke.
Participants in the control arm received standard prevention messages about screening and
lifestyle recommendations for each of the six conditions, such as: “Talk to your health
professional about blood sugar testing [37], as well as information regarding the potential
impact of elevated blood glucose”. Controls did not utilize Family Healthware™ or receive
personalized risk assessments until follow-up, which enabled risk stratification. A total of
3344 individuals completed the entire protocol (n = 2105 intervention arm; n = 1239 control
arm). Retention rates were 79.4% and 77.5%, respectively, for the two arms.
2.2. Health beliefs
Health beliefs were based on the following single item measures using five-point Likert
scales: perceived risk: “Compared to most people your age and sex, what would you say
your chances are for developing ____ (disease)?” (1 = much lower than average to 5 = much
higher than average); perceived control: “There's a lot I can do to prevent _____ (disease).”
(1 = strongly disagree to 5 = strongly agree); worry: “During the past four weeks, how often
have you thought about your chances of getting ____ (disease)?” (1 = not at all to 5 = almost
all the time); perceived severity: “Getting/having ____ (disease) would be a very serious
problem.” (1 = strongly disagree to 5 = strongly agree).
2.3. Familial risk assessments
The Family Healthware™ risk algorithms considered the number of affected family
members for diabetes, CHD and stroke, their degree of relatedness to the proband, lineage,
gender and age at diagnosis. Participants were classified as being either at strong, moderate
or weak familial risk for each condition based on well-established methods [38,39]. Because
individuals with either a moderate or strong familial risk of developing diabetes, CHD or
stroke are significantly more likely to develop these disorders than those with a weak
familial risk, we combined the moderate and strong risk categories and defined this new
group as being at ‘increased familial risk’ for the disease.
2.4. Statistical analysis
We focused on the baseline health belief data obtained from individuals in both the
intervention and control arms. Familial risk distributions were compared between study
arms and were not significantly different for diabetes, CHD or stroke. Therefore, baseline
survey and family history data for the intervention and control arms were combined for the
analysis presented.
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Health beliefs regarding diabetes, CHD and stroke were compared across the three familial
risk groups, defined for the current report, based on the algorithms employed for the Family
Healthware™ tool. Group 1, which served as a control, consisted of 836 individuals who
were not at increased familial risk for either diabetes, CHD or stroke. Individuals at
increased familial risk for diabetes were divided into two subgroups: those with a family
history of diabetes alone (n = 267), which represents Group 2; and those with a family
history of diabetes and CHD (n = 137), diabetes and stroke (n = 52), and diabetes, CHD and
stroke (n = 789), which together comprise Group 3. Individuals with a family history of
CHD and/or stroke, but not diabetes were excluded from the analyses (n = 1263) since our
focus was on those at increased familial risk for diabetes.
Associations between familial risk groups and categorical baseline demographic factors
were examined using the Chi-square test. For the analysis of health beliefs, the baseline
scores of perceived risk, perceived control, worry and perceived severity were treated as
continuous variables. Analysis of variance (ANOVA) was performed to test the differences
in continuous variables (i.e., health belief scores and age) across familial risk groups.
General linear models (GLM) procedure in SAS was used to account for unbalanced design
of the data with ANOVA approach. Multiple linear regression models were constructed for
the adjusted estimates. Least square means were estimated with standard errors.
Data management and statistical analyses were conducted using SAS software (version 9.2,
SAS Institute Inc, Cary, NC). Due to the exploratory nature of the current study, the
significance level (type 1 error of 0.05) was not adjusted for multiple testing.
3. Results
The demographic characteristics for the three familial risk groups are illustrated in Table 1.
Individuals at increased familial risk for diabetes, CHD and/or stroke (Group 3) were
significantly older (p < 0.001), more likely to be female (p = 0.006) and have less education
(p = 0.007) than those who were at increased familial risk for diabetes alone (Group 2) or
those who were not at increased familial risk for any of the metabolic disorders (Group 1).
Individuals in Group 1 were significantly more likely to be white (p < 0.001) and have a
healthy BMI (p < 0.0001) compared to those in Group 2 or Group 3. There were no
differences in smoking status across the three familial risk groups.
Baseline health beliefs are presented in Table 2. In terms of perceived risk for diabetes (p <
0.0001), CHD (p < 0.0001) and stroke (p < 0.0001), scores became significantly higher,
after adjusting for demographic differences between groups, as the number of conditions in
their family history increased. In contrast, there were no significant differences in scores for
perceived control for diabetes (p = 0.21), CHD (p = 0.63) or stroke (p = 0.051). However,
scores for worry about diabetes (p < 0.0001), CHD (p < 0.001) and stroke (p < 0.0001) were
also significantly higher among individuals with the strongest familial risk. Perceived
severity scores for diabetes (p = 0.08), CHD (p = 0.72) and stroke (pt = 0.82) did not vary
significantly across familial risk groups.
4. Discussion
Although several studies have examined health beliefs among individuals at increased
familial risk for diabetes [20–29], little is known about how such perceptions vary when the
family history also consists of individuals with additional metabolic disorders. To our
knowledge, these analyses represent the first evaluation of health beliefs regarding diabetes,
CHD and stroke among individuals with different familial risk profiles for diabetes.
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Having family members affected with CHD and/or stroke, as well as diabetes, had a
significant impact on perceived risk of all three disorders, after adjusting for demographic
differences across familial risk groups. This may be due to the fact that having personal
experience with a chronic disease (i.e., a relative or close friend affected with diabetes, CHD
or stroke) can strengthen health beliefs [40]. It should be noted, however, that most of the
actual scores were less than 3 on a 5-point Likert scale. Thus, despite significant differences
in perceived risk across familial risk groups, most individuals with a family history of these
disorders consider themselves to be at ‘average’ risk.
Previous reports have shown that the majority of individuals with a family history of
diabetes are unaware of their increased risk of developing the disease [22–28]. This may be
due, in part, to optimistic bias regarding future risk, which has been shown to be related to
perceived risk, worry and seriousness for multiple conditions [41]. These findings also stress
the importance of risk communications by clinicians about diabetes, CHD and stroke so that
risk perceptions can become more congruent with actual disease risk.
No differences were observed for perceived control for diabetes, CHD or stroke across
familial risk groups. It has been suggested that knowledge about the health experiences of
other family members will result in a more fatalistic attitude about health [42]. Harwell et al.
[25] reported that individuals with a family history of diabetes were less likely to believe
that the disease could be prevented. In addition, a study from the Netherlands found that
among individuals at increased familial risk for diabetes, those who attributed this to
genetics believed that, at best, they may be able to postpone, but not prevent, its
development [21]. Thus, developing effective prevention approaches for individuals at
increased diabetes familial risk will likely require improving their knowledge about the
modifiable and non-modifiable risk factors for diabetes, CHD and stroke.
It has previously been reported that perceived risk scores were strongly correlated with those
for worry in the FHITr [35]. Thus, it's not surprising that for the subgroup included in this
report, scores for worry increased with increasing familial risk. However, most worry scores
were less than 2 on a 5-point Likert scale. This is consistent with the result of studies from
Oregon [20], the Netherlands [21], Korea [22], England [23] and Ireland [24], where the
vast majority of individuals with a family history of diabetes did not worry about developing
the disease. It has been suggested that some individuals may not be concerned because they
see their affected family members coping with diabetes and following their treatment
regimen [21]. However, two of these studies reported that those who did perceive
themselves to be at increased diabetes risk worried more about developing the disease
[23,24]. Effective interventions for individuals with a family history must assess health
beliefs.
There is a paucity of research regarding lifestyle interventions among individuals at
increased familial risk of diabetes; most studies have focused on those with pre-diabetes. A
Swedish study randomized individuals with a family history of diabetes to one of three
groups: diet alone, diet and exercise and a control group [43]. The diet and exercise
interventions were intensive; there were telephone conversations with participants every 10
days, on average, during the first four months. Those in the intervention groups had
significant improvements in diet, physical activity and metabolic risk factors after 16 weeks,
which were sustained for approximately one year [44]. However, both intervention groups
were comprised of subjects who were related to one another, which may have confounded
the results.
Recently, the results of a larger randomized trial by Pijl et al. illustrated that among
individuals with a family history of diabetes, those who received diabetes information based
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on familial and general risk factors perceived greater control over preventing diabetes (p =
0.03) and reported eating a more healthy diet after three months (p = 0.01) compared to
subjects who received information based on general risk factors alone [45]. There were no
changes in perceived susceptibility, worry or psychological well being in either group at
follow-up. The authors speculated that familial risk information did not result in fatalism,
but may have been more personally relevant and, therefore, has greater potential to lead to
positive lifestyle modifications.
These findings were similar to the most recent report from the FHITr [37]. Those in the
intervention group, who were not at goal at baseline for lifestyle factors, were more likely to
increase their fruit and vegetable intake (OR = 1.29, 95% CI: 1.05–1.58) and their level of
physical activity (OR = 1.47, 95% CI: 1.08–1.98) six months after the intervention
compared to controls. It is not yet known whether this was potentially due to, or mediated
by, changes in health beliefs that may have occurred because of the personalized messages
that included information about actions that could be taken to reduce their familial risk if it
was moderate or strong.
Fear appeal campaigns can be particularly effective if they induce higher levels of perceived
susceptibility or severity, but also include recommendations regarding ways of diminishing
an alleged threat [46]. Simply informing individuals of their increased familial risk for
diabetes is unlikely to be effective in changing health beliefs or behaviors, and may induce
denial or a defensive response. People also need to know about what they can do lower their
risk, and believe they are capable of making the recommendation lifestyle modifications.
This was the approach employed by the DPP [5] and the Finnish DPS [6]. Participants in the
intervention group had case managers who helped them understand their likelihood of
progressing to diabetes and how this could be prevented, as well as address any challenges
that developed as they adopted the intensive intervention. Developing similar methods for
individuals at increased familial risk are likely to be equally effective.
These analyses have several limitations. We restricted our focus to those who were and were
not at increased familial risk for diabetes and its vascular complications. Thus, the findings
cannot be generalized to individuals at increased familial risk for other disorders, such as
cancer. In addition, each health belief for each disease was assessed using a single-item
measure to minimize participate burden. Therefore, a more thorough examination of health
beliefs is warranted. Minorities were under-represented in this study and the sample
consisted of relatively well-educated and healthy individuals. Future studies should target
underserved groups to better understand their health beliefs about diabetes and its
complications. Finally, other risk factors, such as smoking, physical activity and BMI, were
not incorporated into the risk algorithms.
We sought to examine health beliefs associated with diabetes, CHD and stroke among
individuals at increased familial risk for diabetes, which represented approximately 40% of
the FHITr participants. The presence of family members affected with CHD and/or stroke
significantly increased scores for perceived risk and worry about diabetes, CHD and stroke.
However, the data suggest that they did not fully appreciate the extent to which they are
susceptible. A lack of understanding of the inter-relationships of perceived risk among these
conditions has been reported by both qualitative [47] and quantitative evaluations' of persons
with diagnosed diabetes [48]. It has been suggested that underestimation of their increased
risk for CHD and stroke may be due, in part, to the emphasis on glycemic control rather than
hypertension and dyslipidemia in patient management.
This stresses the need for the development of tailored interventions that address risk factors
and health beliefs for diabetes, CHD, as well as stroke among individuals at increased
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familial risk for diabetes, particularly since vascular disturbances often precede the
diagnosis of diabetes by as much as a decade [49]. This could be accomplished by applying
the approach recently proposed by the International Diabetes Federation [3], which
emphasizes the assessment of family health histories for both diabetes and cardiovascular
disease using tools such as Family Healthware™. If health beliefs were also examined, then
personalized health messages could be based on familial risk, as in the FHITr, but also
targeted to address perceptions of risk, control, worry and severity, and emphasizing the
benefits of lifestyle modifications for the prevention of diabetes, as well as its cardiovascular
complications.
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Table 2
Baseline health beliefs of participants across familial risk groups.a
Variables (mean (SE)) Group 1
None (n = 836)
Group 2
Diabetes alone (n = 267)
Group 3
DM and CHD, or stroke (n = 978) p-Value
b
Diabetes
 Perceived risk 2.58 (0.07) 3.22 (0.08) 3.26 (0.06) <0.0001
 Perceived control 4.02 (0.06) 4.09 (0.07) 4.09 (0.05) 0.21
 Worry 1.53 (0.06) 1.91 (0.07) 1.94 (0.06) <0.0001
 Perceived severity 4.55 (0.05) 4.44 (0.06) 4.53 (0.02) 0.08
CHD
 Perceived risk 2.61 (0.06) 2.71 (0.08) 3.13 (0.06) <0.0001
 Perceived control 4.33 (0.05) 4.37 (0.06) 4.35 (0.05) 0.63
 Worry 1.86 (0.07) 1.93 (0.08) 2.10 (0.06) <0.0001
 Perceived severity 4.76 (0.05) 4.80 (0.06) 4.78 (0.05) 0.72
Stroke
 Perceived risk 2.68 (0.06) 2.79 (0.07) 2.99 (0.06) <0.0001
 Perceived control 4.09 (0.06) 4.23 (0.07) 4.14 (0.03) 0.051
 Worry 1.63 (0.06) 1.74 (0.07) 1.80 (0.05) <0.0001
 Perceived severity 4.74 (0.04) 4.75 (0.05) 4.76 (0.04) 0.82
aGroup 1: not at increased familial risk for diabetes, CHD or stroke; Group 2: increased familial risk for diabetes alone; Group 3: increased familial
risk for diabetes and CHD, diabetes and stroke, and diabetes, CHD and stroke.
b
Based on ANOVA for unbalanced design data and adjusted for age, gender, race, education, and BMI.
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